English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease

MPS-Authors
/persons/resource/persons82012

Lawrenz,  Maria
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82197

Visekruna,  Alexander
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82141

Schmidt,  Nicole
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81969

Kaufmann,  Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82175

Steinhoff,  Ulrich
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Lawrenz, M., Visekruna, A., Kuhl, A., Schmidt, N., Kaufmann, S. H. E., & Steinhoff, U. (2012). Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease. Mucosal Immunology, 5(2), 129-139. doi:10.1038/mi.2011.57.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-BE19-0
Abstract
There is no abstract available